Fresenius Medical Care AG & Co. KGaA: Release of a capital market information
- Share buy-back - 16th Interim Report
In the period from September 30, 2019 until and including October 4, 2019, a total of 0 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.
The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange:
Day of repurchase Aggregated volume in number of shares Weighted average share pricein EUR 30.09.2019 - - 01.10.2019 - - 02.10.2019 - - 04.10.2019 - -
The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including October 4, 2019 therefore amounts to 2,997,001 shares.
Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors.
Fresenius Medical Care AG & Co. KGaA represented by Fresenius Medical Care Management AG represented by its Management Board
Bad Homburg v.d.H., October 7, 2019
07.10.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.deLanguage: English Company: Fresenius Medical Care AG & Co. KGaA Else-Kröner-Straße 1 61352 Bad Homburg
Germany Internet: www.freseniusmedicalcare.com End of News DGAP News Service